The US Food and Drug Administration (FDA) has broadened the approval of Furoscix® (furosemide injection) to treat edema in ...

The following is a summary of “Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with ...

Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for subcutaneous (SC) administration via a wearable, single-use, pre-programmed on-body infusor for outpatient ...

Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...

India has donated urgently-needed medicines to Sri Lanka responding to an urgent request from Colombo, the Indian High ...

In response to an urgent request, India has gifted 50,000 ampoules of Furosemide injection (20mg/2ml) to help alleviate a ...

Objectives In severe heart disease, parenteral administration of loop diuretic is often needed. We present clinical outcomes from episodes of care using subcutaneous continuous subcutaneous infusion ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure. Last year, the drug developer noted that FDA feedback from a 2023 Type D ...

The Government of India yesterday donated 50,000 ampoules of Furosemide injection (20mg/2ml) to help address the immediate ...